Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
22/08/2025
Barclays Bank: Downgrades the rating of Gap Inc. from "hold" to "hold and wait"; Target price reduced from $24 to $19.
Latest
1 m ago
On August 22, Reuters reported that Starbucks is expected to receive a non-binding acquisition offer for its Chinese business within two weeks. Starbucks has invited potential bidders such as Spring Capital, Carlyle Group, Hillhouse Capital, and Sequoia Capital to attend a management presentation.
1 m ago
Recently, the oxytocin injection and octreotide acetate injection produced by Shangyao First Biochemical, a subsidiary of Shanghai Pharmaceutical, have been approved for listing in the Philippines with drug registration certificates. Oxytocin is used for induced labor and was approved domestically in 1994; octreotide acetate is used to treat acromegaly and was approved domestically in 2006, passing generic drug consistency evaluation in 2022. Both drugs were listed in the Philippines without additional research and development costs, only registration fees of about 50,000 yuan. In 2024, sales of oxytocin in the Philippine market amounted to 970,000 US dollars. This approval will benefit the expansion of overseas markets, but sales are uncertain due to factors such as policy and exchange rates.
2 m ago
Puleco: The 2.65 billion idling funds raised were managed to maturity, and the principal of 8.21 billion was recovered with a profit of 3.6653 million.
2 m ago
Bao Shi Technology (600794.SH) released its first-half financial results, with a net profit attributable to shareholders of 48.66 million yuan, a decrease of 65.45%.
2 m ago
Hong Kong stocks surge | Jinshang Machine China(01651.HK) jumps over 7%, the company actively deploys emerging downstream areas such as humanoid robots and AIDC liquid cooling.
See all latest